VEGFA +936C/T and -634G/C polymorphisms and gastric cancer risk: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 8, 2011, Pages 1979-1983

  Liu, Hui ^a   Wang, Shaochuang ^b   Huang, Chen ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED HUAIAN NO 1 PEOPLE S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Gastric cancer; Meta analysis; Polymorphism; Vascular endothelial growth factor

Indexed keywords

EID: 84863254310     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Al-Moundhri MS, Al-Nabhani M, Burney IA, et al (2009). Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms-a case-control study in an Omani population. Mol Carcinog, 48, 1170-6.
2. Awata T, Inoue K, Kurihara S, et al (2002). A common polymorphism in the 5'-untranslated region of the VEGF gene is associated with diabetic retinopathy in type 2 diabetes. Diabetes, 51, 1635-9.
3. Awata T, Kurihara S, Takata N, et al (2005). Functional VEGF C-634G polymorphism is associated with development of diabetic macular edema and correlated with macular retinal thickness in type 2 diabetes. Biochem Biophys Res Commun, 333, 679-85.
4. Bae SJ, Ahn DH, Hong SP, et al (2008). Gender-specific association between polymorphism of vascular endothelial growth factor (VEGF 936C>T) gene and patients with stomach cancer. Yonsei Med J, 49, 783-91.
5. Balasubramanian SP, Cox A, Cross SS, et al (2007). Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer, 121, 1009-16.
6. Carmeliet P, Jain RK (2000). Angiogenesis in cancer and other diseases. Nature, 407, 249-57.
7. Chae YS, Kim JG, Sohn SK, et al (2006). Investigation of vascular endothelial growth factor gene polymorphisms and its association with clinicopathologic characteristics in gastric cancer. Oncology, 71, 266-72.
8. Crew KD, Neugut AI (2006). Epidemiology of gastric cancer. World J Gastroenterol, 12, 354-62.
9. Dassoulas K, Gazouli M, Rizos S, et al (2009). Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival. Mol Carcinog, 48, 563-9.
10. Ferrara N (2002). VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer, 2, 795-803.
11. Ferrara N, Davis-Smyth T (1997). The biology of vascular endothelial growth factor. Endocr Rev, 18, 4-25.
12. Guan X, Zhao H, Niu J, et al (2009). The VEGF -634G>C promoter polymorphism is associated with risk of gastric cancer. BMC Gastroenterol, 9, 77.
13. Higgins JP, Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
14. Ke Q, Liang J, Wang LN, et al (2008). Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer. Mol Carcinog, 47, 647-51.
15. Lazar D, Raica M, Sporea I, et al (2006). Tumor angiogenesis in gastric cancer. Rom J Morphol Embryol, 47, 5-13.
16. Renner W, Kotschan S, Hoffmann C, et al (2000). A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res, 37, 443-8.
17. Stevens A, Soden J, Brenchley PE, et al (2003). Haplotype analysis of the polymorphic human vascular endothelial growth factor gene promoter. Cancer Res, 63, 812-6.
18. Tahara T, Shibata T, Nakamura M, et al (2009). Effect of polymorphisms in the 3' untranslated region (3'-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan. Mol Carcinog, 48, 1030-7.
19. Tzanakis N, Gazouli M, Rallis G, et al (2006). Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival. J Surg Oncol, 94, 624-30.
20. Wagner AD, Moehler M (2009). Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era. Curr Opin Oncol, 21, 381-5.
21. Watson CJ, Webb NJ, Bottomley MJ, et al (2000). Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine, 12, 1232-5.
22. Wu K, Nie Y, Guo C, et al (2009). Molecular basis of therapeutic approaches to gastric cancer. J Gastroenterol Hepatol, 24, 37-41.
23. Xia HZ, Wu Q, Liu G, et al (2010). Association of VEGF rs3025039 and rs3025021 with VEGF and COX-2 expression in gastric cancer tissues (Chinese). J Clin Exp Pathol, 26, 139-43.
24. Zhou Y, Li N, Zhuang W, et al (2011). Vascular endothelial growth factor (VEGF) gene polymorphisms and gastric cancer risk in a Chinese Han population. Mol Carcinog, 50, 184-8.
25. Zintzaras E, Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet Epidemiol, 28, 123-37.